2020
DOI: 10.1001/jamainternmed.2019.5731
|View full text |Cite
|
Sign up to set email alerts
|

Facilitating Methadone Use in Hospitals and Skilled Nursing Facilities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
28
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 21 publications
(29 citation statements)
references
References 8 publications
0
28
0
Order By: Relevance
“…In addition, regulations from the Substance Abuse and Mental Health Services Administration limit the starting dose of methadone and may discourage up-titration to effective doses in acute hospital settings. 27 Clinical considerations also limit the rate of dose increases, which may prohibit the prescription of an effective dose by the time of hospital discharge. Different regulations restrict buprenorphine use.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, regulations from the Substance Abuse and Mental Health Services Administration limit the starting dose of methadone and may discourage up-titration to effective doses in acute hospital settings. 27 Clinical considerations also limit the rate of dose increases, which may prohibit the prescription of an effective dose by the time of hospital discharge. Different regulations restrict buprenorphine use.…”
Section: Discussionmentioning
confidence: 99%
“…Transitions of care are a key consideration in evaluating the outcomes observed in our study, since most survivors in our cohort were discharged to subacute facilities. Federal policy, specifically Title 21 of the Code of Federal Regulations, complicates patients’ receipt of MOUD at these facilities, preventing continuation of MOUD started in the inpatient setting unless the patient is already enrolled in an OUD treatment program [ 11 ]. While facilities were expected to continue appropriate therapies after discharge, we were unable to independently verify continuation of MOUD after discharge.…”
Section: Discussionmentioning
confidence: 99%
“…11,18 Patients with substance use disorders and/or those needing opioid agonist therapy often face facility rejections and logistical barriers to accessing methadone or buprenorphine. [19][20][21] Other medically complex needs such as hemodialysis (and transport to and from dialysis sessions), 8,11 isolation due to infection, 8,11 bariatric care, 11,[22][23][24][25] and traumatic brain injury 11,26 are known to leave patients without facilities willing or able to care for them. In a small proportion of cases, prolonged stay patients may have histories of incarceration and face legal delays and limits on facilities willing to accept them.…”
Section: Discussionmentioning
confidence: 99%